New treatment approaches for Hepatitis C are on the horizon

Since its characterization in the late 1980’s, Hepatitis C viral infection has proved difficult to treat.  Progressing from multiweekly Interferon injections to a combination of once weekly Interferon injections and an antiviral antibiotic Ribavirin improved treatment efficacy only from about 10 to 40% with significant side effects.  This has prompted many people infected with Hep C to forego treatment.  New antiviral antibiotics when added to the above or possibly used separately are showing signs of improving response to treatment and in the case of dual antiviral antibiotics, possibly less toxicity.  See the links below for an abstract and abbreviated editorial.  New genetic markers may also help to better target therapy…


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s